Platinum-based chemotherapy in triple-negative breast cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/19/11/1847/509510/mdn395.pdf
Reference32 articles.
1. Triple negative breast cancer: an update;Chia;Adv Breast Cancer,2007
2. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and Her2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry;Bauer;Cancer,2007
3. Triple negative’ breast cancer: a new area for phase III breast cancer clinical trials;Kilburn;Clin Oncol (R Coll Radiol),2008
4. Hallmarks of ‘BRCAness’ in sporadic cancers;Turner;Nat Rev Cancer,2004
5. The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin;Bhattacharyya;J Biol Chem,2000
Cited by 179 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Neoadjuvant docetaxel plus cisplatin versus docetaxel plus doxorubicin and cyclophosphamide in early-stage triple-negative breast cancer (HELEN-001): results from a multicenter, randomized controlled, open-label phase II trial;2024-04-11
2. Liver X receptors induce antiproliferative effects in basal‐like breast cancer;Molecular Oncology;2023-06-30
3. Current landscape of personalized clinical treatments for triple-negative breast cancer;Frontiers in Pharmacology;2022-09-16
4. Hitting Multiple Cellular Targets in Triple-Negative Breast Cancer Using Dual-Action Cisplatin(IV) Prodrugs for Safer Synergistic Chemotherapy;ACS Biomaterials Science & Engineering;2022-05-06
5. Eribulin Mesylate Improves Cisplatin-Induced Cytotoxicity of Triple-Negative Breast Cancer by Extracellular Signal-Regulated Kinase 1/2 Activation;Medicina;2022-04-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3